Editorial: New epidemiological, etiological and management insights into community-acquired pneumonia in children: subregional, regional and global perspectives

Editorial: New epidemiological, etiological and management insights into community-acquired pneumonia in children: subregional, regional and global perspectives

Bibliographic Details
Main Authors:	Adegoke G. Falade, Richard A. Adegbola
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-09-01
Series:	Frontiers in Medicine
Subjects:	community-acquired pneumonia antibiotic guidelines mycoplasma pneumoniae mucus plug antibiotic stewardship under-5
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2023.1275263/full

Similar Items

Etiology of community-acquired pneumonia in adults: a systematic review
by: Saeed Shoar, et al.
Published: (2020-10-01)

Prediction of risk factors of bronchial mucus plugs in children with Mycoplasma pneumoniae pneumonia
by: Jiahui Zhang, et al.
Published: (2021-01-01)

The epidemiology, clinical characteristics, and macrolide susceptibility of Mycoplasma pneumoniae pneumonia in children in Southern Taiwan, 2019–2020
by: Cheng-Yen Kuo, et al.
Published: (2022-08-01)

Evaluation of a Pediatric Community-Acquired Pneumonia Antimicrobial Stewardship Intervention at an Academic Medical Center
by: Lauren Puzz, et al.
Published: (2023-04-01)

Empirical prescribing of penicillin G/V reduces risk of readmission of hospitalized patients with community-acquired pneumonia in Norway: a retrospective observational study
by: June Utnes Høgli, et al.
Published: (2020-06-01)

Characteristics and etiology of hospitalized pediatric community-acquired pneumonia in Taiwan
by: Hsin Chi, et al.
Published: (2020-10-01)

Reduced serum 25(OH)D is closely related to bronchial mucus plug formation in children with mycoplasma pneumonia: A prospective cohort study
by: Jiang Kun, et al.
Published: (2023-01-01)

The impact of a stewardship program on antibiotic administration in community-acquired pneumonia: Results from an observational before-after study
by: Markus Fally, et al.
Published: (2021-02-01)

Mycoplasma pneumonia and Chlamydia pneumonia infection in patients admitted to Beheshti Hospital in Kashan with community-acquired pneumonia
by: Mansoreh Momen Heravi, et al.
Published: (2023-12-01)

Empiric antibiotic therapy in the treatment of community-acquired pneumonia in a general hospital in Saudi Arabia
by: Jaffar A Al-Tawfiq, et al.
Published: (2019-01-01)

Early discontinuation of combination antibiotic therapy in severe community-acquired pneumonia: a retrospective cohort study
by: Pauline Guillot, et al.
Published: (2023-09-01)

INHALE: the impact of using FilmArray Pneumonia Panel molecular diagnostics for hospital-acquired and ventilator-associated pneumonia on antimicrobial stewardship and patient outcomes in UK Critical Care—study protocol for a multicentre randomised controlled trial
by: Juliet High, et al.
Published: (2021-10-01)

Coverage of atypical pathogens for hospitalised patients with community-acquired pneumonia is not guided by clinical parameters
by: Rein Jan Piso, et al.
Published: (2013-09-01)

The effect of taking antibacterial therapy on the outpatient stage and outcomes of community-acquired pneumonia in Tomsk hospitals
by: Daria A. Vinokurova, et al.
Published: (2024-01-01)

Mycoplasma pneumoniae: Atypical Pathogen in Community Acquired Pneumonia
by: Abdul-Rahman Mamdouh Mohammad, et al.
Published: (2020-12-01)

Detection of Mycoplasma pneumoniae in Mexican children with community-acquired pneumonia: experience in a tertiary care hospital
by: Merida-Vieyra J, et al.
Published: (2019-04-01)

The Etiology of Community-Acquired Pneumonia Correlates with Serum Inflammatory Markers in Children
by: August Wrotek, et al.
Published: (2022-09-01)

Impact of COVID-19 on the Epidemiological Features of Mycoplasma pneumoniae Infection in Children with Community-Acquired Pneumonia in Henan, China
by: Lifeng Li, et al.
Published: (2023-02-01)

Performance and impact of a multiplex PCR in ICU patients with ventilator-associated pneumonia or ventilated hospital-acquired pneumonia
by: Nathan Peiffer-Smadja, et al.
Published: (2020-06-01)

A preliminary study on the potential of Mycoplasma pneumoniae to induce dyskaryotic change in respiratory epithelium in adult community-acquired pneumonia
by: Shu-Chang An, et al.
Published: (2016-01-01)

Prevalence of mycoplasma pneumoniae and macrolide resistance in children with community-acquired pneumonia: a case study in a teaching hospital
by: Ali Hosseininasab, et al.
Published: (2021-10-01)

Macrolide-Resistant Mycoplasma pneumoniae in Humans, Ontario, Canada, 2010–2011
by: AliReza Eshaghi, et al.
Published: (2013-09-01)

Fatal Community-Acquired Pneumonia: 18 Years in a Medical Center
by: Ling-Jen Wang, et al.
Published: (2013-02-01)

Comparison of different detection methods for Mycoplasma pneumoniae infection in children with community-acquired pneumonia
by: Mingyu Tang, et al.
Published: (2021-02-01)

Analysis of antibiotic prescriptions in patients with community-acquired pneumonia in clinical practice
by: Taube A.A., et al.
Published: (2022-12-01)

The prevalence of respiratory pathogens in adults with community-acquired pneumonia in an outpatient cohort
by: Chen J, et al.
Published: (2019-07-01)

Severe community-acquired pneumonia caused by Mycoplasma pneumoniae in young female patient
by: Milačić Nena, et al.
Published: (2015-07-01)

Prevalence of Genomic Resistance to Macrolide in Mycoplasma Isolates among Children with Community Acquired Pneumonia
by: Sivasambo Kalpana, et al.
Published: (2022-10-01)

Características clínicas y epidemiológicas de las neumonías adquiridas en la comunidad por Mycoplasma pneumoniae en una población española, 2010-2015
by: David Aguilera-Alonso, et al.
Published: (2019-07-01)

Influence of antibiotics of different groups on the course of community-acquired pneumonia in children
by: N.Yu. Shcherbatiuk, et al.
Published: (2022-12-01)

Aerosolized antibiotics in the treatment of hospital-acquired pneumonia/ventilator-associated pneumonia
by: Yun Jung Jung, et al.
Published: (2022-01-01)

A comparison study between GeXP-based multiplex-PCR and serology assay for Mycoplasma pneumoniae detection in children with community acquired pneumonia
by: Le Wang, et al.
Published: (2017-07-01)

Macrolide-resistant <it>Mycoplasma pneumoniae</it> in adolescents with community-acquired pneumonia
by: Miyashita Naoyuki, et al.
Published: (2012-05-01)

Infection by Mycoplasma pneumoniae and its importance as an etiological agent in childhood community-acquired pneumonias
by: Letícia Alves Vervloet, et al.

Clinical characteristics and serum inflammatory markers of community‐acquired mycoplasma pneumonia in children
by: Fei Fan, et al.
Published: (2023-07-01)

Epidemiologic and clinical characteristics of human bocavirus infection in infants and young children suffering with community acquired pneumonia in Ningxia, China
by: Kai Ji, et al.
Published: (2021-10-01)

Azithromycin Place in the Therapy of Community-Acquired Pneumonia in Children
by: S.A. Kramarev
Published: (2013-03-01)

Reducing antimicrobial overuse through targeted therapy for patients with community-acquired pneumonia: a study protocol for a cluster-randomized factorial controlled trial (CARE-CAP)
by: Abhishek Deshpande, et al.
Published: (2023-09-01)

Predictors of hospital mortality and multidrug-resistant pathogens in hospitalized pneumonia patients residing in the community
by: Tomohiko Ukai, et al.
Published: (2023-12-01)

Short antibiotic courses in community-acquired pneumonia in adults: less is better
by: A. I. Sinopalnikov
Published: (2018-10-01)